LUNG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Pulmonx Corp (LUNG) is not a good buy for a beginner investor with a long-term strategy at this time. The stock is in a bearish trend, has weak financial performance, and lacks positive catalysts or strong trading signals. While hedge funds are buying, the company's fundamentals and technical indicators suggest caution.
The stock is in a bearish trend with MACD negatively expanding, RSI indicating oversold conditions at 19.27, and bearish moving averages (SMA_200 > SMA_20 > SMA_5). The current price is below key support levels, with S1 at 1.269 and S2 at 1.124.
Hedge funds are significantly increasing their positions, with a 1169.71% increase in buying over the last quarter.
No recent news or significant insider trading activity. Financials show declining revenue (-4.91% YoY), net income (-20.87% YoY), and EPS (-24.24% YoY). Analysts have lowered the price target from $6 to $5, citing internal issues.
In Q4 2025, revenue dropped to $22.6M (-4.91% YoY), net income dropped to -$10.4M (-20.87% YoY), and EPS dropped to -0.25 (-24.24% YoY). Gross margin increased to 77.62% (+4.86% YoY), but overall financial performance remains weak.
Canaccord analyst William Plovanic lowered the price target from $6 to $5 but maintained a Buy rating, citing internal issues and a focus on fundamentals. However, this does not align with the stock's current bearish trend and weak financials.
